Conference Roundup: CPDD 87th Annual Scientific Meeting

1 PM – 2:30 PM

Concurrent Workshop, 📍Borgne, Third Floor

• Navigating Clinical Challenges in the Use of Extended-Release Buprenorphine for Opioid Use Disorder in Persons Hospitalized with Infections
  • Alain Litwin, MD, University of South Carolina School of Medicine, CHERISH Research Affiliate, Speaker, “Leveraging Nurse Care Management Models for Post-Hospital Discharge Retention in Medication for Opioid Use Disorder (MOUD) and Infectious Disease Care”

Concurrent Workshop, 📍 Napoleon Ballroom B3, Third Floor

• Harnessing Mobile Health for Persons Who Use Substances: Emerging Programs, Challenges, and Opportunities
  • Adati Tarfa, PharmD, MS, PhD, Yale University Medical School, CHERISH 2024-2025 Pilot Grant Recipient, Speaker, “Transforming Health Delivery: The Benefits and Challenges of a Mobile Pharmacracy Clinic”

10:30 AM – 12 PM

Concurrent Symposia, 📍Napoleon Ballroom B1-2, Third Floor

• Substance Use Disorders and Mental Health Consequences of the Evolving Cannabis PolicyLandscape in the US: Findings From the 2024 National Academies of Sciences Engineering and Medicine (NASEM) Report
  • Rosalie Pacula, PhD, University of Southern California, CHERISH Advisory Board member, Speaker, “Regulating Cannabis Supply and Use in United States: Implications for Health”

3:30 PM – 4:45 PM

Late Breaking Oral Sessions, 📍Grand Ballroom CDE, Fifth Floor

• Integrated Outpatient Treatment of Serious Injection-Related Infections and Opioid Use Disorder: The Buprenorphine plus Outpatient Parenteral Antibiotic Therapy (BOPAT) Study
  • Shashi Kapadia, MD, MS, Weill Cornell Medicine, CHERISH Research Affiliate, Co-author
  • Sean M. Murphy, PhD Weill Cornell Medicine, CHERISH Methodology Core Co-director, Co-author

Forum, 📍Grand Ballroom A, Fifth Floor

• Building on Evidence: What the Evidence Says About (De)Criminalizing Drugs and Harm Reduction
  • Brendan Saloner, PhD, Johns Hopkins Bloomberg School of Public Health, CHERISH Research Affiliate, Speaker, “Mandating Treatment”

5 PM – 6:30 PM

Poster Session 1, 📍Napoleon Ballroom CD, Third Floor

• Linking Women Leaving Jail to Medications for Opioid Use Disorder (MOUD): Costs to Implement Pre-Release Telehealth and Peer Navigation Services
  • Kathryn McCollister, PhD, University of Miami School of Medicine, CHERISH Methodology Core Director, Presenter
  • Don Lochana Ekanayake, MSc, University of Miami School of Medicine, CHERISH Staff, Co-author
  • Erminia Fardone, PhD, University of Miami School of Medicine, CHERISH Staff, Co-author
• Laws Criminalizing the Provision of Smoking Supplies in Contravention of Public Health – A 50-State Survey
  • Czarina Behrends, PhD, MPH, Weill Cornell Medicine, CHERISH Research Affiliate, Co-author
• Association Between Overdose Response and Emotional Distress in A Cohort of People Who Use Drugs
  • Annick Bórquez, PhD, University of California San Diego, CHERISH Research Affiliate, Co-author
• Impact of Receiving Jail-Based Buprenorphine Versus Methadone for Treatment of Opioid Use Disorder on Overdose Mortality After Release from New York City Jails, 2014-2018
  • Noa Krawczyk, PhD, NYU Grossman School of Medicine, CHERISH Research Affiliate, Co-author
• Manifestations of a Potential Xylazine Withdrawal Syndrome: A Retrospective Cohort Study with Nested Case Series
  • Margaret Lowenstein, MD, MSHP, University of Pennsylvania, CHERISH Dissemination & Policy Core Co-director, Co-author
• Comparing Electronic Health Record Data to Self-Reported Substance Use Disorder Among People in HIV Care Participating in a Clinical Trial
  • Marlon Mundt, PhD, University of Wisconsin School of Medicine and Public Health, CHERISH Research Affiliate, Co-author
• “Everyone Should Be Able to Know What Drugs They’re Putting in Their Body. It Shouldn’t Be a Gamble.”: Multi-Level Perspectives on Drug Checking Services Throughout Los Angeles County
  • Chelsea Shover, PhD, University of California, Los Angeles, CHERISH Research Affiliate, Co-author
• High Variability in Methamphetamine Purity: Findings From A Community-Based Drug Checking Program in Los Angeles
  • Chelsea Shover, PhD, University of California, Los Angeles, CHERISH Research Affiliate, Co-author
• Long-Term Mortality of Detoxification Patients and the Impact of Social Determinants of Health – 25-Year Follow-Up of the Health Evaluation and Linkage to Primary Care (HELP) Study
  • Jeffrey Samet, MD, MPH, MA, Boston Medical Center, CHERISH Advisory Board Member, Co-author

8 AM – 9 AM

Oral Session, 📍Grand Ballroom CDE, Fifth Floor

• Estimating the Long-Term Clinical Impact and Costs of a Hypothetical Overdose Prevention Center (OPC) on Injection-Related Infections among People who Inject Drugs (PWID) in Denver, Co
  • Joshua Barocas, MD, University of Colorado Anschutz Medical Campus, CHERISH Research Affiliate, Co-author
• Community Acceptability of the First State-Authorized Overdose Prevention Center in the United States.
  • Brandon Marshall, PhD, Brown University School of Public Health, CHERISH Research Affiliate, Co-author

1:45 PM – 3 PM

Late Breaking Oral, 📍Grand Ballroom B, Fifth Floor

• Peer Intervention to Link Overdose Survivors to Treatment: The Pilot Randomized Clinical Trial
  • Alain Litwin, MD, University of South Carolina School of Medicine, CHERISH Research Affiliate, Co-author
• Repeated-Dose Behavioral Intervention to Reduce Opioid Overdose Among Overdose Survivors with Opioid Use Disorder: A Two-Site Phase III Randomized Controlled Trial
  • Alexander Walley, MD, MSc, Boston Medical Center, CHERISH investigator, Co-Author

Oral Session, 📍Napoleon Ballroom B1-2, Third Floor

• Building A System for Capturing and Reporting Data from Kentucky Overdose Response Effort-Funded Programs
  • Jeffery Talbert, PhD, MA, University of Kentucky, CHERISH Research Affiliate, Co-author

3:30 PM – 4:30 PM

Oral Session, 📍Napoleon Ballroom A1-3, Third Floor

• Self-Reported Experiences and Perspectives on Using Psychedelics to Manage Opioid Use among Participants of Two Reddit Communities
  • Noa Krawczyk, PhD, NYU Grossman School of Medicine, CHERISH Research Affiliate, Presenter

4:45 PM – 5:45 PM

Oral Session, 📍Napoleon Ballroom B1-2, Third Floor

• Polydrug Use Compared to Use of Opioids Only is Associated with Twice the Prevalence of Non-Fatal Overdose
  • Thomas Stopka, PhD, MS, Tufts University School of Medicine, CHERISH Research Affiliate, Co-Author
  • Peter Friedmann, MD, MPH, FASAM, FACP, University of Massachusetts Medical School, CHERISH Research Affiliate, Co-Author

5:45 PM – 7:15 PM

Poster Session 2, 📍Napoleon Ballroom CD, Third Floor

• Are Drug-Induced Homicide Charges Politically Motivated? Evidence from Prosecutor Elections in Pennsylvania, 2015-2023
  • Susan Busch, PhD, Yale School of Public Health, CHERISH Research Affiliate, Co-Author
• Cannabis and Brain Metabolism in People Living with HIV: Insights from Neuroimaging and Gut- Immune Research
  • Erminia Fardone, PhD, University of Miami School of Medicine, CHERISH Staff, Presenter
  • Kathryn McCollister, PhD, University of Miami School of Medicine, CHERISH Methodology Core Director, Co-Author
  • Don Lochana Ekanayake, MSc, University of Miami School of Medicine, CHERISH Staff, Co-Author
• Measuring Take-Home Methadone Using Administrative data: Validation of Candidate Measures
  • Shashi Kapadia, MD, MS, Weill Cornell Medicine, CHERISH Research Affiliate, Presenter
  • Hao Zhang, PhD, MPH, University of Alabama at Birmingham, CHERISH Research Affiliate, Co-author
  • Noa Krawczyk, PhD, NYU Grossman School of Medicine, CHERISH Research Affiliate, Co-author
  • Yuhua Bao, PhD, Weill Cornell Medicine, CHERISH Population Data & Modeling Core investigator, Co-author
• OB/GYN and Family Medicine Providers Stigma towards Patients who Use Drugs and Differences in Drug Screening and Treatment Practices Compared to Other Specialties
  • Daniel Feaster, PhD, MS, University of Miami Miller School of Medicine, CHERISH Research Affiliate, Co-author
• The Association Between Receiving Medications for Opioid Use Disorder and HIV Testing: Findings from the Rural Opioid Initiative
  • Thomas Stopka, PhD, MS, Tufts University School of Medicine, CHERISH Research Affiliate, Co-author
  • Peter Friedmann, MD, MPH, FASAM, FACP, University of Massachusetts Medical School, CHERISH Research Affiliate, Co-author
• Sexual identity, Sexual behavior, and Drug Use Behaviors among People who Use Drugs in the Rural U.S.
  • Thomas Stopka, PhD, MS, Tufts University School of Medicine, CHERISH Research Affiliate, Co-author
  • Peter Friedmann, MD, MPH, FASAM, FACP, University of Massachusetts Medical School, CHERISH Research Affiliate, Co-author
• The Quality of Treatment of Substance Use and Opioid Use Disorder among Medicare Fee-For-Service and Medicare Advantage Beneficiaries
  • Tami Mark, PhD, MBA, RTI International, CHERISH Research Affiliate, Presenter
• Diverging Race/Ethnic Disparities in Tobacco and Marijuana Use Among California Adults
  • Yuyan Shi, PhD, University of California, San Diego, CHERISH Research Affiliate, Co-author
• Estimating the Effective Daily Dose Ingested Among Illicit Methamphetamine Consumers in Los Angeles
  • Chelsea Shover, PhD, University of California, Los Angeles, CHERISH Research Affiliate, Co-author
• Daily Enjoyable Activities During Long-Term Recovery From Opioid Use Disorder: Multilevel Latent Class Analysis of Types of Days and Types of People
  • Lisa Marsch, PhD, Dartmouth College, Co-Author
• Pre-Post Evaluation of a Toolkit to Increase Engagement in Post-Overdose Outreach Among People who Use Cocaine and Methamphetamine
  • Alexander Walley, MD, MSc, Boston Medical Center, CHERISH investigator, Presenter

8 AM – 9 AM

Oral Session, 📍Napoleon Ballroom A1-3, Third Floor

• Utilizing Mobile Medication Units to Increase Access to Methadone for Medically Institutionalized People in New York State: A Geospatial Analysis
  • Noa Krawczyk, PhD, NYU Grossman School of Medicine, CHERISH Research Affiliate, Co-author
  • Brendan Saloner, PhD, Johns Hopkins Bloomberg School of Public Health, CHERISH Research Affiliate, Co-author
• Addressing Gaps in Substance Use Disorder Care for Racial and Ethnic Minorities Through Mobile Pharmacies
  • Adati Tarfa, PharmD, MS, PhD, Yale University Medical School, CHERISH 2024-2025 Pilot Grant Recipient, Presenter

Oral Session, 📍Napoleon Ballroom B3, Third Floor

• Evaluating the Long-Term Clinical and Cost Impact of a Voter-Approved Tax to Expand Peer Support Services and Access to Medications for Opioid Use Disorder
  • Joshua Barocas, MD, University of Colorado Anschutz Medical Campus, CHERISH Research Affiliate, Co-author

9:15 AM – 10:15 AM

Oral Session, 📍Napoleon Ballroom A1-3, Third Floor

• Estimating the Milligrams of Morphine Equivalent Consumed By People That Use Fentanyl in Los Angeles: Clinical and Epidemiological Implications
  • Chelsea Shover, PhD, University of California, Los Angeles, CHERISH Research Affiliate, Co-author

Oral Session, 📍Napoleon Ballroom B3, Third Floor

• Longitudinal Mediation Models for Youth Online Advertising and E-Cigarette Use
  • Kara Rudolph, PhD, MHS, MPH, Columbia University, CHERISH Research Affiliate, Co-author

Mini Symposium, 📍Grand Ballroom A, Fifth Floor

• The New York City Overdose Prevention Centers: Early Findings on the Community-Level Impacts of the First Publicly Recognized Supervised Consumption Services in the United States
  • Brandon Marshall, PhD, Brown University School of Public Health, CHERISH Research Affiliate, Co-Chair

10:45 AM – 12:15 PM

Symposium, 📍Grand Ballroom B, Fifth Floor

• Emerging harm reduction responses to a changing substance use landscape in Latin America
  • Noa Krawczyk, PhD, NYU Grossman School of Medicine, CHERISH Research Affiliate, Chair
  • Annick Bórquez, PhD, University of California San Diego, CHERISH Research Affiliate, Speaker, “The Sudden and Prolonged Methadone Factory Closure in Mexico: Impacts on Patients Receiving Treatment in Tijuana through Quantitative and Qualitative Approaches.”

5:30 PM – 7 PM

Poster Session 3, 📍Napoleon Ballroom CD, Third Floor

• Microcosting the Optimal Method for Advancing Transgender Women with HIV to Viral Suppression
  • Ali Jalali, PhD, MA, Weill Cornell Medicine, CHERISH Research Affiliate, Co-author
  • Sean M. Murphy, PhD Weill Cornell Medicine, CHERISH Methodology Core Co-director, Co-author
• Cost-Effectiveness of Implementation Facilitation to Promote Emergency Department-Initiated Buprenorphine for Opioid Use Disorder
  • Sean M. Murphy, PhD Weill Cornell Medicine, CHERISH Methodology Core Co-director, Presenter
  • Thanh Lu, PhD, RTI International, CHERISH Research Affiliate, Co-author
  • Ali Jalali, PhD, MA, Weill Cornell Medicine, CHERISH Research Affiliate, Co-author
• Racial-Ethnic Disparities in Drug Toxicology Testing among Pregnant Women: A Meta-Analysis of Toxicology for Black Women during Delivery
  • Sugy Choi, MS, PhD, NYU Grossman School of Medicine, CHERISH Research Affiliate, Presenter
• Identifying Social Determinants of Health as Barriers to SUD Recovery in Recovery Management Check-Ups
  • Michael Dennis, PhD, Chestnut Health Systems, CHERISH Research Affiliate, Co-author
• Syndemic Correlates of Non-Fatal GHB Overdose in A US National Sample of Sexual and Gender Minority People
  • Tyler Bartholomew, PhD, University of Miami Miller School of Medicine, CHERISH Research Affiliate, Co-author
• “What’s the Point of Going in Every Morning? Might as Well Just Start Using Again”: A Mixed Methods Study Exploring Attitudes toward Opioid Agonist Therapy during the Overlapping Drug Toxicity Crisis and COVID-19 Pandemic
  • Ahmed Bayoumi, MD, MSc, University of Toronto, CHERISH Research Affiliate, Co-author
• Heroin Use and Return to Treatment Among Methadone Clinic Patients in Tijuana, Mexico Following A Prolonged Methadone Shortage
  • Annick Bórquez, PhD, University of California San Diego, CHERISH Research Affiliate, Co-author
• A Fentanyl Overdose Prevention Intervention Involving Distribution of Fentanyl Test Strips on Non-Fatal Overdose: A Randomized Clinical Trial
  • Brandon Marshall, PhD, Brown University School of Public Health, CHERISH Research Affiliate, Co-author
• Exploring People Who Use Dugs’ Perceptions and Preferences of Overdose Prevention Centers Prior to Their Implementation in Rhode Island
  • Brandon Marshall, PhD, Brown University School of Public Health, CHERISH Research Affiliate, Co-author
• Physician Experiences Implementing Novel Therapeutic Approaches for Withdrawal Management and Induction onto Medications for Opioid Use Disorder in Patients Dependent on Illicitly Manufactured Fentanyl
  • Bohdan Nosyk, PhD, MA, Centre for Health Evaluation and Outcome Sciences (CHÉOS), CHERISH Research Affiliate, Co-author
• Characterizing Substance Use Patterns Across Geographic Locations in the United States
  • Thomas Stopka, PhD, MS, Tufts University School of Medicine, CHERISH Research Affiliate, Co-author
• Temporal Trends in Touchpoints to Identify Individuals at High Risk for Opioid-Related Overdose Death in Massachusetts: 2014-2020
  • Thomas Stopka, PhD, MS, Tufts University School of Medicine, CHERISH Research Affiliate, Co-author
  • Alexander Walley, MD, MSc, Boston Medical Center, CHERISH investigator, Co-author

1 PM – 2 PM

Oral Session, 📍Napoleon Ballroom A1-3, Third Floor

• Predicting Next Year Overdose Death Rates at County Level in the United States: A Statistical and Machine Learning Model Comparison to Produce 2025 Estimates
  • Annick Bórquez, PhD, University of California San Diego, CHERISH Research Affiliate, Presenter
  • Natasha Martin, DPhil, University of California San Diego, CHERISH Research Affiliate, Co-author

Oral Session, 📍Grand Ballroom CDE, Fifth Floor

• Evaluating the Impact of Increased Criminal Penalties for Fentanyl Possession on Initiation and Retention of Medications for Opioid Use Disorder in Colorado
  • Joshua Barocas, MD, University of Colorado Anschutz Medical Campus, CHERISH Research Affiliate, Co-author
• Evaluating the Differential Impact of Criminal Penalties for Fentanyl Possession on Initiation and Retention on Buprenorphine by Insurance Status
  • Joshua Barocas, MD, University of Colorado Anschutz Medical Campus, CHERISH Research Affiliate, Co-author
• Racial Disparities in Opioid-Related Overdose Mortality Following Fentanyl Possession Criminalization Law in Colorado
  • Joshua Barocas, MD, University of Colorado Anschutz Medical Campus, CHERISH Research Affiliate, Co-author

2 PM – 3:30 PM

Poster Session 4, 📍Napoleon Ballroom CD, Third Floor

• Cost per Opioid Free Year: A Systematic Review and Summary Analysis
  • Ali Jalali, PhD, Weill Cornell Medicine, CHERISH Research Affiliate, Co-author
  • Sean M. Murphy, PhD, Weill Cornell Medicine, CHERISH Methodology Core Co-director, Co-author
• Economic Viability of the Consult for Addiction Treatment and Care in Hospitals (CATCH) Program in Six New York City Hospitals
  • Ali Jalali, PhD, Weill Cornell Medicine, CHERISH Research Affiliate, Co-author CHERISH Research Affiliate, Co-author
• Staff Perspectives of Real-World Implementation of Long-Acting Injectable Cabotegravir for Pre-Exposure Prophylaxis at a Low-Barrier Syringe Services Program
  • Tyler Bartholomew, PhD, University of Miami Miller School of Medicine, CHERISH Research Affiliate, Co-author
• Access, Adaptations, and Outcomes in Substance Use Treatment for People with Limited-English Proficiency in the United States: A Scoping Review
  • Sugy Choi, MS, PhD, NYU Grossman School of Medicine, CHERISH Research Affiliate, Co-author
• “You’re Being Watched and Surveilled and Not Trusted.” Perspectives on Urine Drug Testing During the COVID-19 Pandemic: A Thematic Analysis.
  • Ahmed Bayoumi, MD, MSc, University of Toronto, CHERISH Research Affiliate, Co-author
• Lessons Learned in the Early Implementation of Mobile Medications Units in New York
  • Noa Krawczyk, PhD, NYU Grossman School of Medicine, CHERISH Research Affiliate, Co-author
  • Brendan Saloner, PhD, Johns Hopkins Bloomberg School of Public Health, CHERISH Research Affiliate, Co-author
• Outcomes of a Multi-Site Randomized Controlled Trial of an Integrated Care Model of Long-Acting Injectable Buprenorphine with Infectious Disease Treatment among Hospitalized Persons
  • Alain Litwin, MD, University of South Carolina School of Medicine, CHERISH Research Affiliate, Co-author
• Measuring Retention in Opioid Treatment Programs to Reduce Overdose Deaths
  • Tami Mark, PhD, MBA, RTI International, CHERISH Research Affiliate, Presenter
  • Gary Zarkin, PhD, MA, RTI International, CHERISH Research Affiliate, Co-author
• Changes in Methadone Take-Home Dispensing in A Large System of Opioid Treatment Programs
  • Tami Mark, PhD, MBA, RTI International, CHERISH Research Affiliate, Co-author
  • Gary Zarkin, PhD, MA, RTI International, CHERISH Research Affiliate, Co-author
• Lessons Learned in the Early Implementation of Mobile Medications Units in New York
  • Brendan Saloner, PhD, Johns Hopkins Bloomberg School of Public Health, CHERISH Research Affiliate, Co-author
• Disparities in Use and Perceptions of Substance Use and Harm Reduction Services Among Older Adults in the Era of Fentanyl: Results from A Multi-State Survey
  • Brendan Saloner, PhD, Johns Hopkins Bloomberg School of Public Health, CHERISH Research Affiliate, Co-author
• Barriers to Access: Identifying Service Gaps in Los Angeles County’s Syringe Service Programs
  • Chelsea Shover, PhD, University of California, Los Angeles, CHERISH Research Affiliate, Co-author
• Identifying Opioid-Related Incidents Using Machine Learning and Natural Language Processing Using Emergency Medical Services Patient Care Reports
  • Thomas Stopka, PhD, MS, Tufts University School of Medicine, CHERISH Research Affiliate, Co-author
• Naloxone Prescriptions to Adolescents and Young Adults in Massachusetts, 2020-2023
  • Alexander Walley, MD, MSc, Boston Medical Center, CHERISH investigator, Co-author
• Practices of Post Overdose Outreach Programs that Expanded Outreach for Cocaine and Methamphetamine
  • Alexander Walley, MD, MSc, Boston Medical Center, CHERISH investigator, Co-author
• Substitution in Early Addiction Resolution: An Exploration of Substance Use and Mental Health
  • Alexander Walley, MD, MSc, Boston Medical Center, CHERISH investigator, Co-author

↑ Back to Top